Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Get SEC filing alerts via email and in your feed for PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Pacific Biosciences of California, Inc. develops advanced genomic sequencing solutions, including long-read HiFi and short-read SBB technologies, for applications in human genetics, microbiology, oncology, and agriculture. Its products enable comprehensive, accurate genome, transcriptome, and epigenome analysis. Serving research institutions, healthcare, and biotech markets, the company focuses on innovation, high-quality systems, and expanding genomic insights to improve health and biological understanding.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

1
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports $37.2 Million Revenue in Q1 2026, Significant Loss Reduction

Via official filing (AI summary) | 27 days ago | 0 comments

2
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports 4% Revenue Increase to $160M for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports Q3 2025 Financial Results with Revenue Decline and Increased Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports 10% Revenue Growth in Q2 2025, Net Loss Increases to $468M

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports $37.2 Million Revenue in Q1 2025, Operating Loss Surges to $428.9 Million

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports 23% Revenue Decline, Launches New Sequencing Products

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Pacific Biosciences Reports 28% Revenue Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments